Rock Springs Capital Management LP - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 40 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,497,950
+17.4%
1,000,0000.0%0.04%
+33.3%
Q2 2023$1,276,050
-5.6%
1,000,0000.0%0.03%
-6.2%
Q1 2023$1,351,500
-14.8%
1,000,0000.0%0.03%
-15.8%
Q4 2022$1,586,500
+12.3%
1,000,0000.0%0.04%
+5.6%
Q3 2022$1,413,000
+6.4%
1,000,0000.0%0.04%
-7.7%
Q2 2022$1,328,000
+0.6%
1,000,0000.0%0.04%
+18.2%
Q1 2022$1,320,000
+5.0%
1,000,0000.0%0.03%
+13.8%
Q4 2021$1,257,000
-5.9%
1,000,0000.0%0.03%
+3.6%
Q3 2021$1,336,000
-0.8%
1,000,0000.0%0.03%
+3.7%
Q2 2021$1,347,000
-0.5%
1,000,0000.0%0.03%
-10.0%
Q1 2021$1,354,000
-2.6%
1,000,0000.0%0.03%
+3.4%
Q4 2020$1,390,000
+0.4%
1,000,0000.0%0.03%
-17.1%
Q3 2020$1,385,000
-17.2%
1,000,0000.0%0.04%
-23.9%
Q2 2020$1,673,000
+30.0%
1,000,0000.0%0.05%
-13.2%
Q1 2020$1,287,000
-16.2%
1,000,0000.0%0.05%
+8.2%
Q4 2019$1,536,000
+12.0%
1,000,0000.0%0.05%
-10.9%
Q3 2019$1,372,000
+4.2%
1,000,0000.0%0.06%
+14.6%
Q2 2019$1,317,000
-2.7%
1,000,0000.0%0.05%
-7.7%
Q1 2019$1,354,000
+13.2%
1,000,0000.0%0.05%
-7.1%
Q4 2018$1,196,000
-29.9%
1,000,0000.0%0.06%
-9.7%
Q3 2018$1,707,000
+18.0%
1,000,0000.0%0.06%
+10.7%
Q2 2018$1,446,0001,000,0000.06%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 45,447,000$60,497,0001.31%
SHENKMAN CAPITAL MANAGEMENT INC 4,366,000$5,924,0000.54%
Aequim Alternative Investments LP 7,609,000$10,088,0000.43%
MACKAY SHIELDS LLC 27,806,000$37,405,0000.35%
Weiss Asset Management LP 10,000,000$13,290,0000.33%
WOLVERINE ASSET MANAGEMENT LLC 13,230,000$17,541,0000.13%
Polar Asset Management Partners Inc. 7,500,000$9,942,0000.10%
LORD, ABBETT & CO. LLC 22,141,000$29,732,0000.07%
Calamos Advisors LLC 7,500,000$9,967,0000.05%
D. E. Shaw & Co., Inc. 39,270,000$52,046,0000.04%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders